John Harris to Case-Control Studies
This is a "connection" page, showing publications John Harris has written about Case-Control Studies.
Connection Strength
0.322
-
Rosmarin D, Pandya AG, Lebwohl M, Grimes P, Hamzavi I, Gottlieb AB, Butler K, Kuo F, Sun K, Ji T, Howell MD, Harris JE. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet. 2020 07 11; 396(10244):110-120.
Score: 0.129
-
Strassner JP, Rashighi M, Ahmed Refat M, Richmond JM, Harris JE. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 2017 May; 76(5):847-855.e5.
Score: 0.102
-
Sherman S, Duskin-Bitan H, Agiv T, Bar D, Marom-Haham L, Levi A, Mimouni D, Chen LC, Harris JE, Levitt JB, Schonmann Y, Cohen AD, Netzer D. Bidirectional association between vitiligo and melasma: A large-scale population-based study. Indian J Dermatol Venereol Leprol. 2026 Mar-Apr; 92(2):150-156.
Score: 0.048
-
Tissera KA, Buros-Stein A, Delva C, Mayur O, Hawryluk EB, Harris JE, Garza-Mayers AC. Investigation of Hearing Loss in Pediatric Vitiligo. Pediatr Dermatol. 2025 Sep-Oct; 42(5):1016-1019.
Score: 0.044